INTU, also known as inturned planar cell polarity protein, is a crucial regulator of the planar cell polarity (PCP) signaling pathway, which orchestrates the coordinated orientation of cells within epithelial tissues during development. As a core component of the PCP pathway, INTU plays a pivotal role in establishing cellular polarity along the axis perpendicular to the apical-basal axis of epithelial cells. Through its interactions with other PCP proteins, such as VANGL and FZD, INTU contributes to the formation of functional protein complexes that mediate cell-cell communication and signaling events essential for proper tissue morphogenesis and organogenesis. Specifically, INTU functions in the regulation of cellular processes including cell migration, tissue patterning, and morphogenetic movements, ensuring the precise alignment and arrangement of cells within developing tissues.
The activation of INTU within the PCP signaling pathway involves a series of intricate molecular events that modulate its function and activity. One mechanism of activation is through protein-protein interactions, wherein INTU forms complexes with other PCP proteins, leading to the activation of downstream signaling cascades. Additionally, post-translational modifications such as phosphorylation or ubiquitination may regulate INTU's activity, influencing its stability, subcellular localization, and ability to interact with binding partners. Furthermore, INTU activation may be modulated by extracellular cues and environmental signals that regulate the expression and localization of PCP components, thereby initiating signaling events that culminate in the establishment of cellular polarity and tissue patterning. Overall, elucidating the mechanisms of INTU activation provides insights into its pivotal role in PCP signaling and its contribution to the proper development and organization of epithelial tissues.
Items 1 to 10 of 12 total
展示:
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
氯化锂可以抑制GSK-3β,后者是一种参与Wnt信号通路的激酶。由于Wnt信号通路与INTU发挥作用的平面细胞极性通路相交,抑制GSK-3β可以通过调节Wnt信号通路的动态来增强INTU的活性。 | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $70.00 $198.00 | 18 | |
SB-216763 是另一种 GSK-3β 抑制剂。通过抑制 GSK-3β,它可以调节 Wnt 信号传导,从而通过改变信号传导环境,增强 INTU 在平面细胞极性中的作用。 | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $57.00 $184.00 $867.00 | 10 | |
BIO 可选择性地抑制 GSK-3β。它对 GSK-3β 的作用可导致 Wnt 信号的改变,从而间接增强 INTU 在平面细胞极性方面的活性。 | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $153.00 $520.00 | 4 | |
CHIR99021 是 GSK-3β 的强效抑制剂。通过调节 Wnt/β-catenin 信号,CHIR99021 可间接增强 INTU 在平面细胞极性中的功能活性。 | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $94.00 $286.00 | 27 | |
IWP-2 可抑制 Wnt 的产生,从而可能导致 Wnt 和平面细胞极性通路中的补偿机制。这些补偿机制可能会增强 INTU 的活性。 | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $35.00 $115.00 $515.00 | 26 | |
XAV-939通过抑制tankyrase稳定Axin,导致β-catenin降解和Wnt信号改变。这可能会间接增强 INTU 在平面细胞极性方面的活性。 | ||||||
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $210.00 $320.00 $1250.00 | 1 | |
LGK-974 是一种 Porcupine 抑制剂,可阻断 Wnt 配体的分泌。这种抑制可能会通过调节 Wnt 和平面细胞极性信号来间接增强 INTU 的活性。 | ||||||
IWR-1-endo | 1127442-82-3 | sc-295215 sc-295215A | 5 mg 10 mg | $82.00 $132.00 | 19 | |
IWR-1 能稳定 Axin 并抑制 Wnt 反应。这种Axin稳定作用可通过影响平面细胞极性途径间接增强INTU的活性。 | ||||||
JW 55 | 664993-53-7 | sc-364517 sc-364517A | 10 mg 50 mg | $172.00 $726.00 | ||
JW55 可抑制β-catenin 反应性转录物,可能会影响 Wnt 信号转导。这可能会间接增强 INTU 在平面细胞极性中的活性。 | ||||||
KY02111 | 1118807-13-8 | sc-397043 sc-397043A | 5 mg 25 mg | $79.00 $336.00 | ||
KY02111 通过抑制 Wnt 信号转导促进分化。这种抑制可能会通过调节与平面细胞极性交叉的途径间接增强 INTU 的活性。 |